These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32184641)

  • 21. Helicobacter pylori infection is not an independent risk factor of non-alcoholic fatty liver disease in China.
    Wang W; Fan M; Gong R; Zhang Y; Zeng J; Xu S; Lin R
    BMC Gastroenterol; 2022 Feb; 22(1):81. PubMed ID: 35209867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis.
    Mantovani A; Turino T; Altomari A; Lonardo A; Zoppini G; Valenti L; Tilg H; Byrne CD; Targher G
    Metabolism; 2019 Jul; 96():56-65. PubMed ID: 31047909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan.
    Okushin K; Takahashi Y; Yamamichi N; Shimamoto T; Enooku K; Fujinaga H; Tsutsumi T; Shintani Y; Sakaguchi Y; Ono S; Kodashima S; Fujishiro M; Moriya K; Yotsuyanagi H; Mitsushima T; Koike K
    BMC Gastroenterol; 2015 Feb; 15():25. PubMed ID: 25880912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between nonalcoholic fatty liver disease and
    Yan P; Yu B; Li M; Zhao W
    Saudi Med J; 2021 Jul; 42(7):735-741. PubMed ID: 34187917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease.
    Sumida Y; Kanemasa K; Imai S; Mori K; Tanaka S; Shimokobe H; Kitamura Y; Fukumoto K; Kakutani A; Ohno T; Taketani H; Seko Y; Ishiba H; Hara T; Okajima A; Yamaguchi K; Moriguchi M; Mitsuyoshi H; Yasui K; Minami M; Itoh Y
    J Gastroenterol; 2015 Sep; 50(9):996-1004. PubMed ID: 25622927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of
    Xu G; Ma S; Dong L; Mendez-Sanchez N; Li H; Qi X
    Can J Gastroenterol Hepatol; 2023; 2023():5521239. PubMed ID: 36742347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque.
    Yu LY; Hu KC; Liu CJ; Hung CL; Bair MJ; Chen MJ; Wang HY; Wu MS; Shih SC; Liu CC
    Medicine (Baltimore); 2019 Mar; 98(9):e14672. PubMed ID: 30817593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence, Metabolic Profile, and Associated Risk Factors of Non-alcoholic Fatty Liver Disease in an Adult Population of India.
    Singhai A; Yadav V; Joshi R; Malik R; T SB; Kamle S
    Cureus; 2023 Jan; 15(1):e33977. PubMed ID: 36820120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: a systemic review and meta-analysis.
    Ning L; Liu R; Lou X; Du H; Chen W; Zhang F; Li S; Chen X; Xu G
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):735-742. PubMed ID: 30950907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Papatheodorou A; Patsiaoura K; Katsiki E; Zafeiriadou E; Zavos C; Anastasiadou K; Terpos E
    Metabolism; 2013 Jan; 62(1):121-6. PubMed ID: 22841522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori Infection and Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Heydari K; Yousefi M; Alizadeh-Navaei R; Lotfi P; Sheydaee F; Raei M; Vahdatinia A; Hessami A; Rafati S; Moosazadeh M; Ghasemian R; Salehi F; Massoudi H; Ghaffari-Saravi F; Rismantab S
    Turk J Gastroenterol; 2022 Mar; 33(3):171-181. PubMed ID: 35410853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan.
    Tuong TTK; Tran DK; Phu PQT; Hong TND; Dinh TC; Chu DT
    Diagnostics (Basel); 2020 Mar; 10(3):. PubMed ID: 32183383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No evidence for a causal link between
    Liu Y; Xu H; Zhao Z; Dong Y; Wang X; Niu J
    Front Microbiol; 2022; 13():1018322. PubMed ID: 36406444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between Helicobacter pylori infection and polymorphism of adiponectin gene promoter
-11391G/A, superoxide dismutase gene in
nonalcoholic fatty liver disease.
    Zhang C; Guo L; Qin Y; Li G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 41(4):359-66. PubMed ID: 27241145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori and Risk of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Wijarnpreecha K; Thongprayoon C; Panjawatanan P; Manatsathit W; Jaruvongvanich V; Ungprasert P
    J Clin Gastroenterol; 2018; 52(5):386-391. PubMed ID: 28098578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between
    Cai O; Huang Z; Li M; Zhang C; Xi F; Tan S
    Gastroenterol Res Pract; 2018; 2018():8040262. PubMed ID: 29527224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic Fatty Liver Disease Is Associated with
    Xu MY; Ma JH; Du J; Yin J; Liu L; Cui F; Lu QB
    Gastroenterol Res Pract; 2020; 2020():9797841. PubMed ID: 32411211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between Helicobacter pylori with nonalcoholic fatty liver disease assessed by controlled attenuation parameter and other metabolic factors.
    Han YM; Lee J; Choi JM; Kwak MS; Yang JI; Chung SJ; Yim JY; Chung GE
    PLoS One; 2021; 16(12):e0260994. PubMed ID: 34898613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States.
    Kang SJ; Kim HJ; Kim D; Ahmed A
    PLoS One; 2018; 13(8):e0202325. PubMed ID: 30110395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study.
    Newsome PN; Sasso M; Deeks JJ; Paredes A; Boursier J; Chan WK; Yilmaz Y; Czernichow S; Zheng MH; Wong VW; Allison M; Tsochatzis E; Anstee QM; Sheridan DA; Eddowes PJ; Guha IN; Cobbold JF; Paradis V; Bedossa P; Miette V; Fournier-Poizat C; Sandrin L; Harrison SA
    Lancet Gastroenterol Hepatol; 2020 Apr; 5(4):362-373. PubMed ID: 32027858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.